欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1783/001
药品名称
Fosaprepitant Accord
活性成分
FOSAPREPITANT meglumine 37.6 mg/ml
剂型
Powder for solution for infusion
上市许可持有人
Accord Healthcare Limited
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
United Kingdom (Northern Ireland) (XI)
Austria (AT)
Fosaprepitant Accord 150 mg Pulver zur Herstellung einer Infusionslösung
Spain (ES)
Italy (IT)
Sweden (SE)
Norway (NO)
Finland (FI)
许可日期
2018/01/17
最近更新日期
2024/03/08
药物ATC编码
A04AD12 aprepitant
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final Product Information
|
common-interpack
Date of last change:2018/05/04
Final Product Information
|
common-pl-clean
Date of last change:2018/05/04
Final Product Information
|
common-spc-clean
Date of last change:2018/05/04
PAR
|
613644_20180202_PAR_IRS
Date of last change:2018/05/04
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase